.png)
.png)
Total amount raised
$91M
Latest funding date
2026-02-12
Location
OZiva has successfully raised funding over two rounds, with the latest being a Series B round. The company is backed by four investors, including F-Prime and Eight Roads Ventures India.
What Is OZiva?
OZiva, based in Mumbai, Maharashtra, India, is a plant-based clean nutrition brand. The company offers a range of products for fitness, hair, skin, men's health, women's health, and general wellness. It operates in the dietary supplements, fitness, health care, nutrition, and wellness industries.
With an employee count between 101–250, OZiva has made significant strides in the market. The company has been fully acquired by Hindustan Unilever Limited (HUL) and has raised funding across multiple rounds, culminating in a Corporate Round in February 2026.
How Much Funding Has OZiva Raised?
- Angel/Seed Round
- Amount Raised: Undisclosed
- Date: June 2015
- Lead Investors: Undisclosed; known participants include Beerud Sheth and Ravi Mantha
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: Seed capital to launch OZiva's plant-based nutrition platform.
- Series A
- Amount Raised: USD 5,000,000
- Date: June 2020
- Lead Investors: Matrix Partners India
- Other Investors: Titan Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations, enhance product offerings, and expand market reach.
- Series B
- Amount Raised: USD 12,000,000
- Date: March 2021
- Lead Investors: Eight Roads Ventures
- Other Investors: F-Prime Capital, Matrix Partners India
- Valuation at Round: USD 80,000,000
- Motivation Behind the Round: To build out the team, enter new product categories, and scale the technology platform.
- Debt Round (Series B)
- Amount Raised: Undisclosed
- Date: January 2022
- Lead Investors: Stride Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: Venture debt to support growth and expansion ahead of strategic acquisition.
- Corporate Round (Majority Acquisition — 51% Stake)
- Amount Raised: INR 264.28 crore (approx. USD 32,000,000)
- Date: December 2022
- Acquirer: Hindustan Unilever Limited (HUL)
- Valuation at Round: Approx. INR 518 crore (approx. USD 62,940,000)
- Motivation Behind the Round: HUL's entry into the health and wellness category via a majority stake in OZiva.
- Corporate Round (Full Acquisition — Remaining 49% Stake)
- Amount Raised: INR 824 crore (approx. USD 90,990,000)
- Date: February 12, 2026
- Acquirer: Hindustan Unilever Limited (HUL)
- Valuation at Round: Approx. INR 1,682 crore (approx. USD 197,000,000)
- Motivation Behind the Round: Full consolidation of OZiva as a wholly owned subsidiary of HUL, following OZiva's strong performance scaling to approximately INR 480 crore in revenue in 2025.
Total Amount Raised: At least USD 91M based on disclosed funding (USD 17M in VC rounds from 2020–2022, plus HUL's corporate acquisition tranches of approx. USD 32M in December 2022 and USD 90.99M in February 2026). The Seed and Debt round amounts were not publicly disclosed.
Key Investors
- Hindustan Unilever Limited (HUL)
- Details: HUL is one of India's largest FMCG companies and a subsidiary of Unilever. It acquired a 51% majority stake in OZiva in December 2022 and completed full acquisition in February 2026, making OZiva a wholly owned subsidiary.
- Investment Focus Areas: Consumer goods, personal care, health and wellness
- Notable Investments: OZiva, Nutritionalab (divested 2026)
- Eight Roads Ventures
- Details: Eight Roads Ventures is a global venture capital firm that invests in high-growth companies with a strong presence in technology, healthcare, and consumer sectors. It led OZiva's Series B round in March 2021.
- Investment Focus Areas: Technology, healthcare, consumer products
- Notable Investments: Alibaba, App Annie, Neo4j
- F-Prime Capital
- Details: F-Prime Capital is a venture capital firm focused on healthcare and technology investments. It participated in OZiva's Series B round.
- Investment Focus Areas: Biotechnology, medical technology, healthcare IT
- Notable Investments: Denali Therapeutics, Ultragenyx, Orchard Therapeutics
- Matrix Partners India (Z47)
- Details: Matrix Partners India (now rebranded as Z47) is an early-stage investment firm focused on high-growth sectors in India. It led OZiva's Series A and co-invested in the Series B round.
- Investment Focus Areas: Consumer technology, B2B, financial services
- Notable Investments: Ola, Practo, Dailyhunt
- Stride Ventures
- Details: Stride Ventures is a leading venture debt firm in India. It provided debt financing to OZiva in January 2022, supporting the company's growth trajectory ahead of HUL's strategic acquisition.
- Investment Focus Areas: Venture debt for high-growth Indian startups
- Notable Investments: Various D2C and technology startups across India
What's Next for OZiva?
OZiva stands at the cusp of significant growth opportunities. With plans to expand into new product categories and enhance its technology platform, the company aims to empower over 100 million lives. The growing demand for plant-based nutrition and personalized health solutions presents a vast market potential, with the preventive healthcare category alone expected to reach $170 billion by 2024.
As OZiva scales its operations, future fundraising rounds seem likely to support these ambitious goals. The company's focus on innovation and quality positions it well to attract further investment. However, challenges such as intense competition and maintaining product quality while expanding could pose hurdles. Navigating these challenges will be crucial for OZiva's sustained success.
Use Clay to Get Funding Data
Sales professionals, leverage Clay's platform to access comprehensive fundraising data on companies like OZiva and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
